On November 5th, PhotoMedex held a tele conference among its laser partners and the dermatological industry and over 70 people participated.
Areas of discussion were clinical updates on the company’s XTRAC photo therapy laser system which has been cleared for use by professionals for the treatment of Psoriasis, Vitiligo and Atopic Dermatitis (eczema), by the Food and Drug Administration.
In addition to the clinical discussion, the success and progress of reimbursement was discussed to help all involved gain further reimbursement for their patients.
Also, President and CEO, Jeffrey O’Donnell, addressed the company’s current outlook and the recent successful financing.
To access the playback of this conference call dial and enter the access number of 458021. This playback will be available only until November 19th.
The statements or opinions in this teleconference presentation do not necessarily reflect the position of PhotoMedex. Some of the information discussed may be based on the views of independent practitioners and the results they have experienced using the XTRAC system.